Episode 66: Breakthrough Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue episode artwork

EPISODE · Jun 10, 2021 · 13 MIN

Episode 66: Breakthrough Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue

from ShockWaveNews · host ShockWaveNews

Breakthrough Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue

Breakthrough Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue

NOW PLAYING

Episode 66: Breakthrough Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue

0:00 13:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of ShockWaveNews?

This episode is 13 minutes long.

When was this ShockWaveNews episode published?

This episode was published on June 10, 2021.

What is this episode about?

Breakthrough Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue

Can I download this ShockWaveNews episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!